Translating “Big Data” in Oncology for Clinical Benefit: Progress or Paralysis

The molecular characterization of cancer through genomics, data from multiomics technologies, molecular-driven clinical trials, and internet-enabled devices capturing patient context and real-world data are creating an unprecedented big data revolution across the cancer research-care continuum. Whil...

Descripción completa

Detalles Bibliográficos
Autores principales: Barker, Anna D., Lee, Jerry S.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Controversy and Consensus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306452/
https://www.ncbi.nlm.nih.gov/pubmed/35416976
http://dx.doi.org/10.1158/0008-5472.CAN-22-0100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306452/
https://www.ncbi.nlm.nih.gov/pubmed/35416976
http://dx.doi.org/10.1158/0008-5472.CAN-22-0100

Ejemplares similares